Antineoplastic agent, Tyrosine kinase inhibitor Medicines in UAE
144 medicines available
About Antineoplastic agent, Tyrosine kinase inhibitor Medicines
This page lists all Antineoplastic agent, Tyrosine kinase inhibitor medicines available in UAE pharmacies.
Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.
Complete List of Antineoplastic agent, Tyrosine kinase inhibitor Medicines
Class: | Spleen tyrosine kinase (SYK) inhibitor
Use: | Treatment of chronic immune thrombocytopenic purpura (ITP) in adults who have had an insufficient response to other treatments
Adult dose: | ...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearra...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation
Adult dose: | 120 mg orally once daily, taken co...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation
Adult dose: | 120 mg orally once daily; may be r...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of advanced or metastatic breast cancer, particularly in combination with capecitabine in patients with HER2-positive tumors
Adult dose: | 1250 ...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of advanced or metastatic breast cancer, particularly in combination with capecitabine in patients with HER2-positive tumors
Adult dose: | 1250 ...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of differentiated thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma
Adult dose: | 10 mg orally once daily, taken with or withou...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients who have progressed on or are intolerant to...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients who have progressed on or are intolerant to...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adults with acute myeloid leukemia (AML) with a FLT3 mutation and for the treatment of aggressive systemic mastocytosis (ASM)
Adult dose: | 5...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with acute myeloid leukemia (AML) with a FLT3 mutation and for the treatment of aggressive systemic mastocytosis (ASM)
Adult d...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with early-stage HER2-positive breast cancer, following adjuvant trastuzumab-based therapy; also indicated for metastatic HER2-p...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of chronic myeloid leukemia (CML) in adult and pediatric patients with Philadelphia chromosome-positive (Ph+) CML in chronic phase, accelerated ph...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of chronic myeloid leukemia (CML) in patients with Philadelphia chromosome-positive (Ph+) CML in chronic phase, accelerated phase, or blast crisis...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of chronic myeloid leukemia (CML) in adults and pediatric patients with Philadelphia chromosome-positive (Ph+) CML in chronic phase or accelerated...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with newly diagnosed chronic phase Philadelphia chromosome-positive chronic myeloid leukemia (CML) and for patients with CML who...